Zimmer Biomet (ZBH)

Company Profile

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.

Company profile

Ticker

ZBH

Exchange

NYSE

Website

www.zimmerbiomet.com

CEO

Bryan Hanson

Incorporated

Delaware

Location

Indiana

Fiscal year end

Dec 31

Sector

Manufacturing > Electromedical and Electrotherapeutic Apparatus Manufacturing

Industry (SIC)

Orthopedic, Prosthetic & Surgical Appliances & Supplies

Enovis • Steris • Intuitive Surgical • Avanos Medical • Edwards Lifesciences • Invacare • MSA Safety • Align Technology • Surgalign • RTI Surgical ...

Former names

ZIMMER HOLDINGS INC

SEC CIK

0001136869

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

A&E Advanced Closure Systems, LLC • A&E Medical Corp. • Alto Development Corp. • Biomet Biologics, LLC • Biomet CV Holdings, LLC • Biomet Fair Lawn LLC • Biomet International • Biomet International, Inc. • Biomet Leasing, Inc. • Biomet Manufacturing, LLC ...

IRS number

134151777

ZBH stock data

1M 1Y 5Y

Analyst ratings and price targets

Last 3 months

Average target

$119.58

Low target

$17.60

High target

$144.00

Latest filings (excl ownership)

View all

8-K

Zimmer Biomet Announces

3 Feb 23

8-K

Amendments to Articles of Incorporation or Bylaws

2 Nov 22

Zimmer Biomet Announces Third Quarter 2022 Financial Results

2 Nov 22

8-K

Entry into a Material Definitive Agreement

2 Aug 22

Zimmer Biomet Announces Second Quarter 2022 Financial Results

Conflict minerals disclosure

23 May 22

Transcripts

View all

ZBH

Earnings call transcript

2022 Q4

3 Feb 23

ZBH

Earnings call transcript

2022 Q2

2 Aug 22

ZBH

Earnings call transcript

2022 Q1

3 May 22

ZBH

Earnings call transcript

2021 Q4

7 Feb 22

ZBH

Earnings call transcript

2021 Q3

4 Nov 21

ZBH

Earnings call transcript

2021 Q2

3 Aug 21

ZBH

Earnings call transcript

2021 Q1

4 May 21

ZBH

Earnings call transcript

2020 Q4

5 Feb 21

ZBH

Earnings call transcript

2020 Q3

6 Nov 20

ZBH

Earnings call transcript

2020 Q2

4 Aug 20

Latest ownership filings

View all

Financial summary

Financial statements Chart ZBH financial data

Quarter (USD)	Sep 22	Jun 22	Mar 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 21	Dec 20	Dec 19	Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	545.40 mm	545.40 mm	545.40 mm	545.40 mm	545.40 mm	545.40 mm
Cash burn (monthly)	(no burn)	31.18 mm	(no burn)	(no burn)	(no burn)	(no burn)
Cash used (since last report)	n/a	131.39 mm	n/a	n/a	n/a	n/a
Cash remaining	n/a	414.01 mm	n/a	n/a	n/a	n/a
Runway (months of cash)	n/a	13.3	n/a	n/a	n/a	n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2022

ZBH institutional ownership history Ownership history

84.1% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	874	921	-5.1%
Opened positions	55	91	-39.6%
Closed positions	102	109	-6.4%
Increased positions	279	280	-0.4%
Reduced positions	331	339	-2.4%

13F shares	Current	Prev Q	Change
Total value	18.46 bn	19.50 bn	-5.3%
Total shares	176.51 mm	185.59 mm	-4.9%
Total puts	236.10 k	279.70 k	-15.6%
Total calls	582.01 k	357.01 k	+63.0%
Total put/call ratio	0.4	0.8	-48.2%

Largest owners	Shares	Value	Change
Vanguard	23.81 mm	$2.49 bn	+1.0%
BLK Blackrock	21.49 mm	$2.25 bn	+3.3%
T. Rowe Price	10.55 mm	$1.10 bn	+18.1%
JPM JPMorgan Chase & Co.	7.76 mm	$811.54 mm	-30.2%
American Century Companies	5.90 mm	$616.51 mm	-0.2%
Dodge & Cox	5.35 mm	$559.81 mm	-1.0%
Capital International Investors	5.00 mm	$522.59 mm	-23.1%
Primecap Management	4.91 mm	$513.08 mm	-0.0%
BEN Franklin Resources	4.50 mm	$470.17 mm	-0.4%
Geode Capital Management	4.12 mm	$430.57 mm	+2.4%

Largest transactions	Shares	Bought/sold	Change
STT State Street	0.00	-8.81 mm	EXIT
JPM JPMorgan Chase & Co.	7.76 mm	-3.36 mm	-30.2%
Citadel Advisors	2.20 mm	+2.16 mm	+5070.6%
T. Rowe Price	10.55 mm	+1.62 mm	+18.1%
Capital International Investors	5.00 mm	-1.50 mm	-23.1%
Millennium Management	1.32 mm	+1.06 mm	+413.0%
Balyasny Asset Management	1.18 mm	+1.05 mm	+781.7%
Capital Research Global Investors	1.61 mm	-920.26 k	-36.4%
Arrowstreet Capital, Limited Partnership	1.29 mm	+777.00 k	+152.5%
Point72 Asset Management	1.29 mm	+755.86 k	+142.1%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

ZBH insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
1 Feb 23	Zimmer Biomet	Common Stock	Sell	Dispose S	No	No	9.5665	5,131,946	49.09 mm	0
31 Dec 22	Bernard Betsy J	Phantom Stock Units Common Stock	Grant	Acquire A	No	No	126.97	246.122	31.25 k	17,186.743
31 Dec 22	Begley Christopher B	Phantom Stock Units Common Stock	Grant	Acquire A	No	No	126.97	295.346	37.50 k	16,254.054
31 Dec 22	Higgins Arthur J	Phantom Stock Units Common Stock	Grant	Acquire A	No	No	126.97	255.966	32.50 k	30,156.977
31 Dec 22	Hagemann Robert	Phantom Stock Units Common Stock	Grant	Acquire A	No	No	126.97	265.811	33.75 k	25,422.714